Literature DB >> 8712559

Laparoscopic fundoplication: a three-year review.

R Jones1, D F Canal, M M Inman, F J Rescorla.   

Abstract

Laparoscopic treatment of gastroesophageal reflux disease provides decreased postoperative pain and shortens hospitalization. Experience with this procedure continues to grow. The charts of patients who had laparoscopic fundoplication for the treatment of symptomatic refractory gastroesophageal reflux over a three year period were reviewed. Age, sex, preoperative evaluation, surgical technique, length of procedure, length of hospitalization, time to regular diet, conversion to laparotomy, complications, and long-term outcome were analyzed. Eighty-eight patients, 39 females and 49 males, underwent laparoscopic gastric fundoplication. All patients has symptomatic gastroesophageal reflux. Preoperative evaluation including upper endoscopy demonstrated esophagitis in 71 patients (81%) with changes of Barrett's esophagitis in 12 patients (14%). Decreased lower esophageal sphincter pressures were found in 33 of 73 patients (45%) and none had abnormal motility identified. A 2-3 cm fundoplication with nonabsorbable suture was performed over a large dilator. Mean operative time was 109 minutes. The mean length of hospitalization was 1.9 days in patients completed laparoscopically and six days in the 3 patients that required conversion to celiotomy for completion of their fundoplication. A clear liquid diet was offered the evening of surgery and advanced to regular as tolerated. Mild dysphagia was found in most patients for the first week and full liquid or soft diet was prescribed. All but seven patients advanced to regular diet by two weeks. Operative complications occurred in four patients and included two pneumothoraces and two esophageal perforations. Follow-up to 40 months has identified one partial wrap disruption and one crural breakdown both repaired laparoscopically. Seventy-seven patients (88%) have remained asymptomatic and off all medication. Laparoscopic fundoplication is safe and effective, allowing the benefits of minimal access surgery, including decreased postoperative pain and disability.

Entities:  

Mesh:

Year:  1996        PMID: 8712559

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Internal herniation of the anterior gastric wall through an attenuated Nissen Fundoplication wrap: an unusual complication and its laparoscopic management.

Authors:  D Chattopadhyay; K S Wynne
Journal:  Hernia       Date:  2010-08-08       Impact factor: 4.739

Review 2.  The current role of laparoscopic surgery for gastroesophageal reflux disease in infants and children.

Authors:  T E Lobe
Journal:  Surg Endosc       Date:  2007-01-02       Impact factor: 4.584

3.  Incidence of delayed gastric emptying associated with revisional laparoscopic paraesophageal hernia repair.

Authors:  Miller Carlton Hamrick; Steven S Davis; Amar Chiruvella; Rebecca L Coefield; J Patrick Waring; John F Sweeney; Edward Lin
Journal:  J Gastrointest Surg       Date:  2012-08-16       Impact factor: 3.452

4.  Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model.

Authors:  Joseph Romagnuolo; Michael A Meier; Daniel C Sadowski
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

5.  Laparoscopic Nissen fundoplication in children: 2-5-year follow-up.

Authors:  M C Bourne; C Wheeldon; G A MacKinlay; F D Munro
Journal:  Pediatr Surg Int       Date:  2003-09-09       Impact factor: 1.827

6.  Long-term results (6-10 years) of laparoscopic fundoplication.

Authors:  Giovanni Zaninotto; Giuseppe Portale; Mario Costantini; Christian Rizzetto; Emanuela Guirroli; Martina Ceolin; Renato Salvador; Sabrina Rampado; Oberdan Prandin; Alberto Ruol; Ermanno Ancona
Journal:  J Gastrointest Surg       Date:  2007-07-10       Impact factor: 3.452

7.  Left hepatic vein injury during laparoscopic antireflux surgery for large para-oesophageal hiatus hernia.

Authors:  Anish P Nagpal; Harshad Soni; Sanjiv P Haribhakti
Journal:  J Minim Access Surg       Date:  2009 Jul-Sep       Impact factor: 1.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.